Jaco C. Bleeker

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Three years of ocular proton therapy in the Netherlands, clinical results.

Three years of ocular proton therapy in the Netherlands, clinical results.

Journal: Acta ophthalmologica

Published: January 08, 2026

Clinical outcomes of pars plana vitrectomy with endoresection in uveal melanoma primarily treated with plaque radiotherapy or proton beam therapy.

Clinical outcomes of pars plana vitrectomy with endoresection in uveal melanoma primarily treated with plaque radiotherapy or proton beam therapy.

Journal: European journal of ophthalmology

Published: December 17, 2025

Prognosis and determinants of survival after orbital exenteration for conjunctival melanoma: Experiences from a Dutch Referral Centre.

Prognosis and determinants of survival after orbital exenteration for conjunctival melanoma: Experiences from a Dutch Referral Centre.

Journal: Acta ophthalmologica

Published: February 13, 2025

Clinical outcomes and risk factors for local failure and visual impairment in patients treated with Ru-106 brachytherapy for uveal melanoma.

Clinical outcomes and risk factors for local failure and visual impairment in patients treated with Ru-106 brachytherapy for uveal melanoma.

Journal: Clinical and translational radiation oncology

Published: December 11, 2024

Choroidal melanoma patient views on the importance of treatment characteristics and outcomes, and physicians' information provision in the Netherlands.

Choroidal melanoma patient views on the importance of treatment characteristics and outcomes, and physicians' information provision in the Netherlands.

Journal: Acta ophthalmologica

Published: December 05, 2024

Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1.

Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1.

Journal: Ophthalmology science

Published: October 29, 2022

Clinical Outcomes after International Referral of Uveal Melanoma Patients for Proton Therapy.

Clinical Outcomes after International Referral of Uveal Melanoma Patients for Proton Therapy.

Journal: Cancers

Published: November 19, 2021

Anterior Segment OCTA of Melanocytic Lesions of the Conjunctiva and Iris.

Anterior Segment OCTA of Melanocytic Lesions of the Conjunctiva and Iris.

Journal: American journal of ophthalmology

Published: July 01, 2020

Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time.

Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time.

Journal: Ocular oncology and pathology

Published: March 10, 2020

RETINAL OXIMETRY IS ALTERED IN EYES WITH CHOROIDAL MELANOMA BUT NOT IN EYES WITH CHOROIDAL NEVI.

RETINAL OXIMETRY IS ALTERED IN EYES WITH CHOROIDAL MELANOMA BUT NOT IN EYES WITH CHOROIDAL NEVI.

Journal: Retina (Philadelphia, Pa.)

Published: December 19, 2019

Management of conjunctival melanoma with local excision and adjuvant brachytherapy.

Management of conjunctival melanoma with local excision and adjuvant brachytherapy.

Journal: Eye (London, England)

Published: November 20, 2019

Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines.

Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines.

Journal: Cancers

Published: June 30, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026